Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v1-EN
Language French English
Date Updated 2023-03-27 2023-03-13
Drug Identification Number 00343617 00343617
Brand name ROFACT ROFACT
Common or Proper name Rofact Rofact
Company Name BAUSCH HEALTH, CANADA INC. BAUSCH HEALTH, CANADA INC.
Ingredients RIFAMPIN RIFAMPIN
Strength(s) 300MG 300MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 300 300
ATC code J04AB J04AB
ATC description DRUGS FOR TREATMENT OF TUBERCULOSIS DRUGS FOR TREATMENT OF TUBERCULOSIS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2023-03-27 2023-03-27
Actual start date
Estimated end date 2023-04-03 2023-04-03
Actual end date 2023-03-24
Shortage status Avoided shortage Anticipated shortage
Tier 3 Status No No
Company comments Delays in outside lab testing Delays in outside lab testing
Health Canada comments